Analysts Have Conflicting Sentiments on These Healthcare Companies: EBOS Group Limited (AU:EBO), Craneware (GB:CRW) and GlaxoSmithKline (GB:GSK)
GSK Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
GSK Analyst Ratings
Jefferies Upgrades GSK to Buy, Raises Price Target to $48
GSK Analyst Ratings
Berenberg Bank Adjusts GSK Price Target to $41 From $44, Maintains Buy Rating
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
Analysts' Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), CompuGroup Medical (GB:0MSD) and GlaxoSmithKline (GB:GSK)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amedisys (AMED), Atrys Health SA (Frankfurt: DE:A2T) and GlaxoSmithKline (GB:GSK)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
RBC Downgrades BELLUS Health to Sector Perform From Outperform, Cuts Price Target to $14.75 From $21 Amid GSK Deal; Speculative Risk Kept
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GSK), Karyopharm Therapeutics (KPTI) and Eyenovia (EYEN)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aeterna Zentaris (AEZS), Delcath Systems (DCTH) and GlaxoSmithKline (GSK)
GSK PLC Target Raised to 1,700p From 1,500p by Deutsche Bank
GSK PLC Raised to Buy From Hold by Deutsche Bank
GlaxoSmithKline (GSK) Receives a Sell From Bank of America Securities
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GSK), Teladoc (TDOC) and Cue Biopharma (CUE)
No Data